Market revenue in 2023 | USD 17.8 million |
Market revenue in 2030 | USD 27.2 million |
Growth rate | 6.2% (CAGR from 2023 to 2030) |
Largest segment | Attenuated vaccine |
Fastest growing segment | DNA Vaccines |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Attenuated Vaccine, Inactivated Vaccine, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines |
Key market players worldwide | Lonza Group Ltd, FUJIFILM Holdings Corp, Merck KGaA, Catalent Inc, Icon PLC, Syngene, Curia, Ajinomoto Co Inc, IDT Biologika |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to vaccine contract manufacturing market will help companies and investors design strategic landscapes.
Attenuated vaccine was the largest segment with a revenue share of 30.34% in 2023. Horizon Databook has segmented the Saudi Arabia vaccine contract manufacturing market based on attenuated vaccine, inactivated vaccine, subunit vaccines, toxoid vaccines, dna vaccines covering the revenue growth of each sub-segment from 2018 to 2030.
The clinical trials administration is formed to provide services professionally by evaluating, registering, and monitoring trials conducted in Saudi Arabia, which helps protect clinical trial subjects and improves the experience of clinical research investigators while strengthening the capacity of regulatory bodies and legislative & oversight functions.
Over 1,150 trials were registered in Saudi Arabia as of April 2023. The majority of these studies are being conducted for cancer, neurology, cardiology, infectious diseases, and other diseases. Saudi Arabia has the largest population in the Gulf, which is expected to increase at annual average growth of more than 2% over the next 5 years.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia vaccine contract manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia vaccine contract manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account